Global Oncolytic Virus Therapy Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Oncolytic Virus Therapy market size is predicted to grow from US$ 11.2 million in 2025 to US$ 44.3 million in 2031; it is expected to grow at a CAGR of 25.8% from 2025 to 2031.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
LPI (LP Information)' newest research report, the “Oncolytic Virus Therapy Industry Forecast” looks at past sales and reviews total world Oncolytic Virus Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Therapy sales for 2025 through 2031. With Oncolytic Virus Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Therapy industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncolytic Virus Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Oncolytic Virus Therapy market size is predicted to grow from US$ 11.2 million in 2025 to US$ 44.3 million in 2031; it is expected to grow at a CAGR of 25.8% from 2025 to 2031.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
LPI (LP Information)' newest research report, the “Oncolytic Virus Therapy Industry Forecast” looks at past sales and reviews total world Oncolytic Virus Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Therapy sales for 2025 through 2031. With Oncolytic Virus Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Therapy industry.
This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncolytic Virus Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncolytic Virus Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- HSV-based Oncolytic Viruses
- Adenoviruses-based Oncolytic Viruses
- Vaccinia Virus-based Oncolytic Viruses
- Vesicular Stomatitis Virus-based Oncolytic Viruses
- Newcastle Disease Virus-based Oncolytic Viruses
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Oncolytics Biotech
- Viralytics
- Transgene SA
- Oncolys BioPharma
- Targovax
- PsiOxus Therapeutics
- SillaJen Biotherapeutics
- Sorrento Therapeutics
- Lokon Pharma
- Genelux Corporation
- Vyriad
- TILT Biotherapeutics
- Cold Genesys
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Therapy Market Size (2020-2031)
2.1.2 Oncolytic Virus Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oncolytic Virus Therapy by Country/Region (2020, 2024 & 2031)
2.2 Oncolytic Virus Therapy Segment by Type
2.2.1 HSV-based Oncolytic Viruses
2.2.2 Adenoviruses-based Oncolytic Viruses
2.2.3 Vaccinia Virus-based Oncolytic Viruses
2.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.2.5 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy Market Size by Type
2.3.1 Oncolytic Virus Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
2.4 Oncolytic Virus Therapy Segment by Application
2.4.1 Melanoma
2.4.2 Prostate Cancer
2.4.3 Breast Cancer
2.4.4 Ovarian Cancer
2.4.5 Others
2.5 Oncolytic Virus Therapy Market Size by Application
2.5.1 Oncolytic Virus Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
3 ONCOLYTIC VIRUS THERAPY MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Therapy Market Size Market Share by Player
3.1.1 Global Oncolytic Virus Therapy Revenue by Player (2020-2025)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Oncolytic Virus Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS THERAPY BY REGION
4.1 Oncolytic Virus Therapy Market Size by Region (2020-2025)
4.2 Global Oncolytic Virus Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncolytic Virus Therapy Market Size Growth (2020-2025)
4.4 APAC Oncolytic Virus Therapy Market Size Growth (2020-2025)
4.5 Europe Oncolytic Virus Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncolytic Virus Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oncolytic Virus Therapy Market Size by Country (2020-2025)
5.2 Americas Oncolytic Virus Therapy Market Size by Type (2020-2025)
5.3 Americas Oncolytic Virus Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Therapy Market Size by Region (2020-2025)
6.2 APAC Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.3 APAC Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Therapy Market Size by Country (2020-2025)
7.2 Europe Oncolytic Virus Therapy Market Size by Type (2020-2025)
7.3 Europe Oncolytic Virus Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Therapy by Region (2020-2025)
8.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET FORECAST
10.1 Global Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.1.1 Global Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.1.2 Americas Oncolytic Virus Therapy Forecast
10.1.3 APAC Oncolytic Virus Therapy Forecast
10.1.4 Europe Oncolytic Virus Therapy Forecast
10.1.5 Middle East & Africa Oncolytic Virus Therapy Forecast
10.2 Americas Oncolytic Virus Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Oncolytic Virus Therapy Forecast
10.2.2 Canada Market Oncolytic Virus Therapy Forecast
10.2.3 Mexico Market Oncolytic Virus Therapy Forecast
10.2.4 Brazil Market Oncolytic Virus Therapy Forecast
10.3 APAC Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.3.1 China Oncolytic Virus Therapy Market Forecast
10.3.2 Japan Market Oncolytic Virus Therapy Forecast
10.3.3 Korea Market Oncolytic Virus Therapy Forecast
10.3.4 Southeast Asia Market Oncolytic Virus Therapy Forecast
10.3.5 India Market Oncolytic Virus Therapy Forecast
10.3.6 Australia Market Oncolytic Virus Therapy Forecast
10.4 Europe Oncolytic Virus Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Oncolytic Virus Therapy Forecast
10.4.2 France Market Oncolytic Virus Therapy Forecast
10.4.3 UK Market Oncolytic Virus Therapy Forecast
10.4.4 Italy Market Oncolytic Virus Therapy Forecast
10.4.5 Russia Market Oncolytic Virus Therapy Forecast
10.5 Middle East & Africa Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Oncolytic Virus Therapy Forecast
10.5.2 South Africa Market Oncolytic Virus Therapy Forecast
10.5.3 Israel Market Oncolytic Virus Therapy Forecast
10.5.4 Turkey Market Oncolytic Virus Therapy Forecast
10.6 Global Oncolytic Virus Therapy Forecast by Type (2026-2031)
10.7 Global Oncolytic Virus Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oncolytic Virus Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Oncolytic Virus Therapy Product Offered
11.1.3 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Information
11.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Offered
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Oncolytics Biotech Main Business Overview
11.2.5 Oncolytics Biotech Latest Developments
11.3 Viralytics
11.3.1 Viralytics Company Information
11.3.2 Viralytics Oncolytic Virus Therapy Product Offered
11.3.3 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Viralytics Main Business Overview
11.3.5 Viralytics Latest Developments
11.4 Transgene SA
11.4.1 Transgene SA Company Information
11.4.2 Transgene SA Oncolytic Virus Therapy Product Offered
11.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Transgene SA Main Business Overview
11.4.5 Transgene SA Latest Developments
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Information
11.5.2 Oncolys BioPharma Oncolytic Virus Therapy Product Offered
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Oncolys BioPharma Main Business Overview
11.5.5 Oncolys BioPharma Latest Developments
11.6 Targovax
11.6.1 Targovax Company Information
11.6.2 Targovax Oncolytic Virus Therapy Product Offered
11.6.3 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Targovax Main Business Overview
11.6.5 Targovax Latest Developments
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Information
11.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Offered
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 PsiOxus Therapeutics Main Business Overview
11.7.5 PsiOxus Therapeutics Latest Developments
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Information
11.8.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offered
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 SillaJen Biotherapeutics Main Business Overview
11.8.5 SillaJen Biotherapeutics Latest Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Offered
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sorrento Therapeutics Main Business Overview
11.9.5 Sorrento Therapeutics Latest Developments
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Information
11.10.2 Lokon Pharma Oncolytic Virus Therapy Product Offered
11.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lokon Pharma Main Business Overview
11.10.5 Lokon Pharma Latest Developments
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Information
11.11.2 Genelux Corporation Oncolytic Virus Therapy Product Offered
11.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Genelux Corporation Main Business Overview
11.11.5 Genelux Corporation Latest Developments
11.12 Vyriad
11.12.1 Vyriad Company Information
11.12.2 Vyriad Oncolytic Virus Therapy Product Offered
11.12.3 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Vyriad Main Business Overview
11.12.5 Vyriad Latest Developments
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Information
11.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Offered
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 TILT Biotherapeutics Main Business Overview
11.13.5 TILT Biotherapeutics Latest Developments
11.14 Cold Genesys
11.14.1 Cold Genesys Company Information
11.14.2 Cold Genesys Oncolytic Virus Therapy Product Offered
11.14.3 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Cold Genesys Main Business Overview
11.14.5 Cold Genesys Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Therapy Market Size (2020-2031)
2.1.2 Oncolytic Virus Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oncolytic Virus Therapy by Country/Region (2020, 2024 & 2031)
2.2 Oncolytic Virus Therapy Segment by Type
2.2.1 HSV-based Oncolytic Viruses
2.2.2 Adenoviruses-based Oncolytic Viruses
2.2.3 Vaccinia Virus-based Oncolytic Viruses
2.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.2.5 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy Market Size by Type
2.3.1 Oncolytic Virus Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
2.4 Oncolytic Virus Therapy Segment by Application
2.4.1 Melanoma
2.4.2 Prostate Cancer
2.4.3 Breast Cancer
2.4.4 Ovarian Cancer
2.4.5 Others
2.5 Oncolytic Virus Therapy Market Size by Application
2.5.1 Oncolytic Virus Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
3 ONCOLYTIC VIRUS THERAPY MARKET SIZE BY PLAYER
3.1 Oncolytic Virus Therapy Market Size Market Share by Player
3.1.1 Global Oncolytic Virus Therapy Revenue by Player (2020-2025)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Oncolytic Virus Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS THERAPY BY REGION
4.1 Oncolytic Virus Therapy Market Size by Region (2020-2025)
4.2 Global Oncolytic Virus Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncolytic Virus Therapy Market Size Growth (2020-2025)
4.4 APAC Oncolytic Virus Therapy Market Size Growth (2020-2025)
4.5 Europe Oncolytic Virus Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncolytic Virus Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oncolytic Virus Therapy Market Size by Country (2020-2025)
5.2 Americas Oncolytic Virus Therapy Market Size by Type (2020-2025)
5.3 Americas Oncolytic Virus Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Therapy Market Size by Region (2020-2025)
6.2 APAC Oncolytic Virus Therapy Market Size by Type (2020-2025)
6.3 APAC Oncolytic Virus Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncolytic Virus Therapy Market Size by Country (2020-2025)
7.2 Europe Oncolytic Virus Therapy Market Size by Type (2020-2025)
7.3 Europe Oncolytic Virus Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncolytic Virus Therapy by Region (2020-2025)
8.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET FORECAST
10.1 Global Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.1.1 Global Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.1.2 Americas Oncolytic Virus Therapy Forecast
10.1.3 APAC Oncolytic Virus Therapy Forecast
10.1.4 Europe Oncolytic Virus Therapy Forecast
10.1.5 Middle East & Africa Oncolytic Virus Therapy Forecast
10.2 Americas Oncolytic Virus Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Oncolytic Virus Therapy Forecast
10.2.2 Canada Market Oncolytic Virus Therapy Forecast
10.2.3 Mexico Market Oncolytic Virus Therapy Forecast
10.2.4 Brazil Market Oncolytic Virus Therapy Forecast
10.3 APAC Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.3.1 China Oncolytic Virus Therapy Market Forecast
10.3.2 Japan Market Oncolytic Virus Therapy Forecast
10.3.3 Korea Market Oncolytic Virus Therapy Forecast
10.3.4 Southeast Asia Market Oncolytic Virus Therapy Forecast
10.3.5 India Market Oncolytic Virus Therapy Forecast
10.3.6 Australia Market Oncolytic Virus Therapy Forecast
10.4 Europe Oncolytic Virus Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Oncolytic Virus Therapy Forecast
10.4.2 France Market Oncolytic Virus Therapy Forecast
10.4.3 UK Market Oncolytic Virus Therapy Forecast
10.4.4 Italy Market Oncolytic Virus Therapy Forecast
10.4.5 Russia Market Oncolytic Virus Therapy Forecast
10.5 Middle East & Africa Oncolytic Virus Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Oncolytic Virus Therapy Forecast
10.5.2 South Africa Market Oncolytic Virus Therapy Forecast
10.5.3 Israel Market Oncolytic Virus Therapy Forecast
10.5.4 Turkey Market Oncolytic Virus Therapy Forecast
10.6 Global Oncolytic Virus Therapy Forecast by Type (2026-2031)
10.7 Global Oncolytic Virus Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oncolytic Virus Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Oncolytic Virus Therapy Product Offered
11.1.3 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Information
11.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Offered
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Oncolytics Biotech Main Business Overview
11.2.5 Oncolytics Biotech Latest Developments
11.3 Viralytics
11.3.1 Viralytics Company Information
11.3.2 Viralytics Oncolytic Virus Therapy Product Offered
11.3.3 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Viralytics Main Business Overview
11.3.5 Viralytics Latest Developments
11.4 Transgene SA
11.4.1 Transgene SA Company Information
11.4.2 Transgene SA Oncolytic Virus Therapy Product Offered
11.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Transgene SA Main Business Overview
11.4.5 Transgene SA Latest Developments
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Information
11.5.2 Oncolys BioPharma Oncolytic Virus Therapy Product Offered
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Oncolys BioPharma Main Business Overview
11.5.5 Oncolys BioPharma Latest Developments
11.6 Targovax
11.6.1 Targovax Company Information
11.6.2 Targovax Oncolytic Virus Therapy Product Offered
11.6.3 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Targovax Main Business Overview
11.6.5 Targovax Latest Developments
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Information
11.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Offered
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 PsiOxus Therapeutics Main Business Overview
11.7.5 PsiOxus Therapeutics Latest Developments
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Information
11.8.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offered
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 SillaJen Biotherapeutics Main Business Overview
11.8.5 SillaJen Biotherapeutics Latest Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Offered
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sorrento Therapeutics Main Business Overview
11.9.5 Sorrento Therapeutics Latest Developments
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Information
11.10.2 Lokon Pharma Oncolytic Virus Therapy Product Offered
11.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lokon Pharma Main Business Overview
11.10.5 Lokon Pharma Latest Developments
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Information
11.11.2 Genelux Corporation Oncolytic Virus Therapy Product Offered
11.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Genelux Corporation Main Business Overview
11.11.5 Genelux Corporation Latest Developments
11.12 Vyriad
11.12.1 Vyriad Company Information
11.12.2 Vyriad Oncolytic Virus Therapy Product Offered
11.12.3 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Vyriad Main Business Overview
11.12.5 Vyriad Latest Developments
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Information
11.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Offered
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 TILT Biotherapeutics Main Business Overview
11.13.5 TILT Biotherapeutics Latest Developments
11.14 Cold Genesys
11.14.1 Cold Genesys Company Information
11.14.2 Cold Genesys Oncolytic Virus Therapy Product Offered
11.14.3 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Cold Genesys Main Business Overview
11.14.5 Cold Genesys Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncolytic Virus Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncolytic Virus Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of HSV-based Oncolytic Viruses
Table 4. Major Players of Adenoviruses-based Oncolytic Viruses
Table 5. Major Players of Vaccinia Virus-based Oncolytic Viruses
Table 6. Major Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 7. Major Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 8. Oncolytic Virus Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Table 11. Oncolytic Virus Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Table 14. Global Oncolytic Virus Therapy Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Oncolytic Virus Therapy Revenue Market Share by Player (2020-2025)
Table 16. Oncolytic Virus Therapy Key Players Head office and Products Offered
Table 17. Oncolytic Virus Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Oncolytic Virus Therapy Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Table 22. Global Oncolytic Virus Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Oncolytic Virus Therapy Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Oncolytic Virus Therapy Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Oncolytic Virus Therapy Market Size Market Share by Country (2020-2025)
Table 26. Americas Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Table 28. Americas Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Table 30. APAC Oncolytic Virus Therapy Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Table 32. APAC Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Oncolytic Virus Therapy Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Oncolytic Virus Therapy Market Size Market Share by Country (2020-2025)
Table 36. Europe Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncolytic Virus Therapy Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Oncolytic Virus Therapy
Table 42. Key Market Challenges & Risks of Oncolytic Virus Therapy
Table 43. Key Industry Trends of Oncolytic Virus Therapy
Table 44. Global Oncolytic Virus Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Oncolytic Virus Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Oncolytic Virus Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Amgen Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 49. Amgen Oncolytic Virus Therapy Product Offered
Table 50. Amgen Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Amgen Main Business
Table 52. Amgen Latest Developments
Table 53. Oncolytics Biotech Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 54. Oncolytics Biotech Oncolytic Virus Therapy Product Offered
Table 55. Oncolytics Biotech Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Oncolytics Biotech Main Business
Table 57. Oncolytics Biotech Latest Developments
Table 58. Viralytics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 59. Viralytics Oncolytic Virus Therapy Product Offered
Table 60. Viralytics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Viralytics Main Business
Table 62. Viralytics Latest Developments
Table 63. Transgene SA Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 64. Transgene SA Oncolytic Virus Therapy Product Offered
Table 65. Transgene SA Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Transgene SA Main Business
Table 67. Transgene SA Latest Developments
Table 68. Oncolys BioPharma Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 69. Oncolys BioPharma Oncolytic Virus Therapy Product Offered
Table 70. Oncolys BioPharma Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Oncolys BioPharma Main Business
Table 72. Oncolys BioPharma Latest Developments
Table 73. Targovax Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 74. Targovax Oncolytic Virus Therapy Product Offered
Table 75. Targovax Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Targovax Main Business
Table 77. Targovax Latest Developments
Table 78. PsiOxus Therapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 79. PsiOxus Therapeutics Oncolytic Virus Therapy Product Offered
Table 80. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. PsiOxus Therapeutics Main Business
Table 82. PsiOxus Therapeutics Latest Developments
Table 83. SillaJen Biotherapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 84. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offered
Table 85. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. SillaJen Biotherapeutics Main Business
Table 87. SillaJen Biotherapeutics Latest Developments
Table 88. Sorrento Therapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 89. Sorrento Therapeutics Oncolytic Virus Therapy Product Offered
Table 90. Sorrento Therapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Sorrento Therapeutics Main Business
Table 92. Sorrento Therapeutics Latest Developments
Table 93. Lokon Pharma Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 94. Lokon Pharma Oncolytic Virus Therapy Product Offered
Table 95. Lokon Pharma Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Lokon Pharma Main Business
Table 97. Lokon Pharma Latest Developments
Table 98. Genelux Corporation Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 99. Genelux Corporation Oncolytic Virus Therapy Product Offered
Table 100. Genelux Corporation Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Genelux Corporation Main Business
Table 102. Genelux Corporation Latest Developments
Table 103. Vyriad Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 104. Vyriad Oncolytic Virus Therapy Product Offered
Table 105. Vyriad Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Vyriad Main Business
Table 107. Vyriad Latest Developments
Table 108. TILT Biotherapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 109. TILT Biotherapeutics Oncolytic Virus Therapy Product Offered
Table 110. TILT Biotherapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. TILT Biotherapeutics Main Business
Table 112. TILT Biotherapeutics Latest Developments
Table 113. Cold Genesys Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 114. Cold Genesys Oncolytic Virus Therapy Product Offered
Table 115. Cold Genesys Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Cold Genesys Main Business
Table 117. Cold Genesys Latest Developments
Table 1. Oncolytic Virus Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncolytic Virus Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of HSV-based Oncolytic Viruses
Table 4. Major Players of Adenoviruses-based Oncolytic Viruses
Table 5. Major Players of Vaccinia Virus-based Oncolytic Viruses
Table 6. Major Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 7. Major Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 8. Oncolytic Virus Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Table 11. Oncolytic Virus Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Table 14. Global Oncolytic Virus Therapy Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Oncolytic Virus Therapy Revenue Market Share by Player (2020-2025)
Table 16. Oncolytic Virus Therapy Key Players Head office and Products Offered
Table 17. Oncolytic Virus Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Oncolytic Virus Therapy Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Table 22. Global Oncolytic Virus Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Oncolytic Virus Therapy Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Oncolytic Virus Therapy Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Oncolytic Virus Therapy Market Size Market Share by Country (2020-2025)
Table 26. Americas Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Table 28. Americas Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Table 30. APAC Oncolytic Virus Therapy Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Table 32. APAC Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Oncolytic Virus Therapy Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Oncolytic Virus Therapy Market Size Market Share by Country (2020-2025)
Table 36. Europe Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncolytic Virus Therapy Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Oncolytic Virus Therapy
Table 42. Key Market Challenges & Risks of Oncolytic Virus Therapy
Table 43. Key Industry Trends of Oncolytic Virus Therapy
Table 44. Global Oncolytic Virus Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Oncolytic Virus Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Oncolytic Virus Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Amgen Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 49. Amgen Oncolytic Virus Therapy Product Offered
Table 50. Amgen Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Amgen Main Business
Table 52. Amgen Latest Developments
Table 53. Oncolytics Biotech Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 54. Oncolytics Biotech Oncolytic Virus Therapy Product Offered
Table 55. Oncolytics Biotech Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Oncolytics Biotech Main Business
Table 57. Oncolytics Biotech Latest Developments
Table 58. Viralytics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 59. Viralytics Oncolytic Virus Therapy Product Offered
Table 60. Viralytics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Viralytics Main Business
Table 62. Viralytics Latest Developments
Table 63. Transgene SA Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 64. Transgene SA Oncolytic Virus Therapy Product Offered
Table 65. Transgene SA Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Transgene SA Main Business
Table 67. Transgene SA Latest Developments
Table 68. Oncolys BioPharma Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 69. Oncolys BioPharma Oncolytic Virus Therapy Product Offered
Table 70. Oncolys BioPharma Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Oncolys BioPharma Main Business
Table 72. Oncolys BioPharma Latest Developments
Table 73. Targovax Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 74. Targovax Oncolytic Virus Therapy Product Offered
Table 75. Targovax Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Targovax Main Business
Table 77. Targovax Latest Developments
Table 78. PsiOxus Therapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 79. PsiOxus Therapeutics Oncolytic Virus Therapy Product Offered
Table 80. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. PsiOxus Therapeutics Main Business
Table 82. PsiOxus Therapeutics Latest Developments
Table 83. SillaJen Biotherapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 84. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offered
Table 85. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. SillaJen Biotherapeutics Main Business
Table 87. SillaJen Biotherapeutics Latest Developments
Table 88. Sorrento Therapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 89. Sorrento Therapeutics Oncolytic Virus Therapy Product Offered
Table 90. Sorrento Therapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Sorrento Therapeutics Main Business
Table 92. Sorrento Therapeutics Latest Developments
Table 93. Lokon Pharma Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 94. Lokon Pharma Oncolytic Virus Therapy Product Offered
Table 95. Lokon Pharma Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Lokon Pharma Main Business
Table 97. Lokon Pharma Latest Developments
Table 98. Genelux Corporation Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 99. Genelux Corporation Oncolytic Virus Therapy Product Offered
Table 100. Genelux Corporation Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Genelux Corporation Main Business
Table 102. Genelux Corporation Latest Developments
Table 103. Vyriad Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 104. Vyriad Oncolytic Virus Therapy Product Offered
Table 105. Vyriad Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. Vyriad Main Business
Table 107. Vyriad Latest Developments
Table 108. TILT Biotherapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 109. TILT Biotherapeutics Oncolytic Virus Therapy Product Offered
Table 110. TILT Biotherapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. TILT Biotherapeutics Main Business
Table 112. TILT Biotherapeutics Latest Developments
Table 113. Cold Genesys Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 114. Cold Genesys Oncolytic Virus Therapy Product Offered
Table 115. Cold Genesys Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Cold Genesys Main Business
Table 117. Cold Genesys Latest Developments
LIST OF FIGURES
Figure 1. Oncolytic Virus Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncolytic Virus Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncolytic Virus Therapy Sales Market Share by Country/Region (2024)
Figure 8. Oncolytic Virus Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncolytic Virus Therapy Market Size Market Share by Type in 2024
Figure 10. Oncolytic Virus Therapy in Melanoma
Figure 11. Global Oncolytic Virus Therapy Market: Melanoma (2020-2025) & ($ millions)
Figure 12. Oncolytic Virus Therapy in Prostate Cancer
Figure 13. Global Oncolytic Virus Therapy Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 14. Oncolytic Virus Therapy in Breast Cancer
Figure 15. Global Oncolytic Virus Therapy Market: Breast Cancer (2020-2025) & ($ millions)
Figure 16. Oncolytic Virus Therapy in Ovarian Cancer
Figure 17. Global Oncolytic Virus Therapy Market: Ovarian Cancer (2020-2025) & ($ millions)
Figure 18. Oncolytic Virus Therapy in Others
Figure 19. Global Oncolytic Virus Therapy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Oncolytic Virus Therapy Market Size Market Share by Application in 2024
Figure 21. Global Oncolytic Virus Therapy Revenue Market Share by Player in 2024
Figure 22. Global Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Oncolytic Virus Therapy Value Market Share by Country in 2024
Figure 28. United States Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Oncolytic Virus Therapy Market Size Market Share by Region in 2024
Figure 33. APAC Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Figure 35. China Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Oncolytic Virus Therapy Market Size Market Share by Country in 2024
Figure 42. Europe Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 61. United States Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 65. China Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 69. India Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 72. France Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 73. UK Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 80. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 1. Oncolytic Virus Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncolytic Virus Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncolytic Virus Therapy Sales Market Share by Country/Region (2024)
Figure 8. Oncolytic Virus Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncolytic Virus Therapy Market Size Market Share by Type in 2024
Figure 10. Oncolytic Virus Therapy in Melanoma
Figure 11. Global Oncolytic Virus Therapy Market: Melanoma (2020-2025) & ($ millions)
Figure 12. Oncolytic Virus Therapy in Prostate Cancer
Figure 13. Global Oncolytic Virus Therapy Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 14. Oncolytic Virus Therapy in Breast Cancer
Figure 15. Global Oncolytic Virus Therapy Market: Breast Cancer (2020-2025) & ($ millions)
Figure 16. Oncolytic Virus Therapy in Ovarian Cancer
Figure 17. Global Oncolytic Virus Therapy Market: Ovarian Cancer (2020-2025) & ($ millions)
Figure 18. Oncolytic Virus Therapy in Others
Figure 19. Global Oncolytic Virus Therapy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Oncolytic Virus Therapy Market Size Market Share by Application in 2024
Figure 21. Global Oncolytic Virus Therapy Revenue Market Share by Player in 2024
Figure 22. Global Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Oncolytic Virus Therapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Oncolytic Virus Therapy Value Market Share by Country in 2024
Figure 28. United States Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Oncolytic Virus Therapy Market Size Market Share by Region in 2024
Figure 33. APAC Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Figure 35. China Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Oncolytic Virus Therapy Market Size Market Share by Country in 2024
Figure 42. Europe Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Oncolytic Virus Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 61. United States Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 65. China Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 69. India Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 72. France Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 73. UK Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
Figure 80. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Oncolytic Virus Therapy Market Size 2026-2031 ($ millions)
More Publications
Global Oncolytic Virus Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
July 2018
132 pages
